Skye Bioscience Inc
Change company Symbol lookup
Select an option...
SKYE Skye Bioscience Inc
UVV Universal Corp
LNC Lincoln National Corp
FMCCG Federal Home Loan Mortgage Corp
CSAN Cosan SA
SAIC Science Applications International Corp
MUR Murphy Oil Corp
SPHD Invesco S&P 500® High Dividend Low Volatility ETF
CODI Compass Diversified Holdings
MDRRP Medalist Diversified Reit Inc
Go

Health Care : Biotechnology |
Company profile

Skye Bioscience, Inc. is a biopharmaceutical company, which is focused on the discovery, development, and commercialization of cannabinoid-derived therapeutics, with clinical and commercial differentiation for the treatment of glaucoma diseases. The Company’s products programs include THCVHS and CBDVHS. The Company's lead candidate, THCVHS, is a prodrug of tetrahydrocannabinol (THC), is a topical formulation under development for the treatment of glaucoma and ocular hypertension (OHT). It chemically modifies THC to create a unique synthetic molecule with the intent to realize the known positive effects of THC. Its molecule enables enhanced local delivery in the eye, reduced systemic side effects, and the potential for neuroprotection for the treatment of ocular diseases. CBDVHS is a proprietary analog of cannabidiol (CBD) that has demonstrated biological activity that is both pharmacologically and therapeutically distinct from CBD in various preclinical models.

Closing Price
$0.0474
Day's Change
0.0007 (1.50%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.049
Day's Low
0.0425
Volume
(Average)
Volume:
1,475,614

10-day average volume:
1,630,683
1,475,614
  • Prev Close
    0.0467
  • Today's Open
    0.0467
  • Day's Range
    0.0425-0.049
  • Avg Vol (10-day)
    1.6M
  • Last (time)
    3:59p ET 01/27/22
  • Last (size)
    10.0K
  • 52-Wk Range
    0.041 - 0.2589
    LowHigh
  • (06/02/21 - 01/25/22)
    15.61%
  • 109.2%
  • Market Cap
    22.6M
  • Shares Outstanding
    476.1M
  • -0.02
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.4
  • 3.35
  • --

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.